Table 2.
Characteristics of PCa patients and controls
| Characteristics | Patients, n (%) (n = 262) | Controls, n (%) (n = 270) | P |
|---|---|---|---|
| Age | |||
| <50 | 8(3.0) | 9(3.3) | 0.729 |
| 50-59 | 18(6.9) | 20(7.4) | |
| 60-69 | 83(31.7) | 86(31.9) | |
| 70-79 | 123(46.9) | 130(48.1) | |
| ≥80 | 30(11.5) | 25(9.3) | |
| Average age | 70.7 ± 8.4 | 70.2 ± 8.5 | |
| Smoking status | |||
| Nonsmoking | 102 (38.9%) | 109(40.4%) | 0.734 |
| smoking | 160(61.1%) | 161(59.6%) | |
| History of prostate cancer | |||
| Yes | 14(5.3) | 6(2.2) | 0.067 |
| No | 248(94.7) | 264(97.8) | |
| PSA (ng/ml) | |||
| Average concentration | 128.33 ± 634.21 | 2.146 ± 0.954 | <0.001 |
| ≤10 | 80(30.5) | ||
| >10 | 182(69.5) | ||
| Gleason score | |||
| ≤7 | 72(27.5) | ||
| >7 | 161(62.5) | ||
| missing | 29(11.0) | ||
| Clinical T Stage | |||
| ≤T2 | 93(35.5) | ||
| >T2 | 156(59.5) | ||
| missing | 13(5.0) | ||
| Agressive status | |||
| Early stage | 72(27.5) | ||
| Advanced stage | 180(68.7) | ||
| missing | 10(3.8) |